Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Albert Deisseroth"'
Autor:
Richard Pazdur, Ann T. Farrell, Reena Philip, Albert Deisseroth, Rajeshwari Sridhara, Donna Roscoe, Yuan Li Shen, Donna Przepiorka, Aaron Schetter, Qing Xu, Emily Y. Jen
Grouped terms used in safety analyses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4bb3c71a1ae3311a34043cbf269cfa88
https://doi.org/10.1158/1078-0432.22474197.v1
https://doi.org/10.1158/1078-0432.22474197.v1
Autor:
Richard Pazdur, Ann T. Farrell, Kirsten B. Goldberg, Gene M. Williams, Rosane Charlab, Christopher M. Sheth, Yuan-Li Shen, Albert Deisseroth, Donna Przepiorka, Sarah E. Dorff, Ramadevi Gudi, Vicky Hsu, Lola Luo, Kelly J. Norsworthy
Rate of CR+CRh by subgroup
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2be902c39ee395a68d595086357bb634
https://doi.org/10.1158/1078-0432.22469381.v1
https://doi.org/10.1158/1078-0432.22469381.v1
Autor:
Richard Pazdur, Ann T. Farrell, Reena Philip, Albert Deisseroth, Rajeshwari Sridhara, Donna Roscoe, Yuan Li Shen, Donna Przepiorka, Aaron Schetter, Qing Xu, Emily Y. Jen
On March 29, 2018, the FDA granted accelerated approval for blinatumomab (Blincyto; Amgen, Inc.) for the treatment of adults and children with B-cell precursor acute lymphoblastic leukemia (BCP ALL) in first or second complete remission with minimal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4633f148f2828c48b9597e5e86f99f2c
https://doi.org/10.1158/1078-0432.c.6528714
https://doi.org/10.1158/1078-0432.c.6528714
Autor:
Richard Pazdur, Ann T. Farrell, Reena Philip, Albert Deisseroth, Rajeshwari Sridhara, Donna Roscoe, Yuan Li Shen, Donna Przepiorka, Aaron Schetter, Qing Xu, Emily Y. Jen
RFS by baseline MRD level from Study 20120148
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39411af126f6f2d40456d9d1f9609510
https://doi.org/10.1158/1078-0432.22474200
https://doi.org/10.1158/1078-0432.22474200
Autor:
Richard Pazdur, Ann T. Farrell, Kirsten B. Goldberg, Gene M. Williams, Rosane Charlab, Christopher M. Sheth, Yuan-Li Shen, Albert Deisseroth, Donna Przepiorka, Sarah E. Dorff, Ramadevi Gudi, Vicky Hsu, Lola Luo, Kelly J. Norsworthy
Preferred Terms included in grouped terms
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::477f921b3577155839505aca83b12450
https://doi.org/10.1158/1078-0432.22469378
https://doi.org/10.1158/1078-0432.22469378
Autor:
Richard Pazdur, Gideon M. Blumenthal, Kirsten B. Goldberg, Albert Deisseroth, Frances Namuswe, Donna Przepiorka, Xu Michael Di, Michael L. Manning, Xianhua Cao, Chao Liu, Runyan Jin, Ruo-Jing Li
Supplementary Table S1. Grouped Terms Used In The Safety Analysis; Supplementary Table S2. Selected Grade > 3 Adverse Reactions by Treatment Phase in Study DFCI 11-001
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3003c5aa3d26fdb8027857cee2a73583
https://doi.org/10.1158/1078-0432.22472799.v1
https://doi.org/10.1158/1078-0432.22472799.v1
Autor:
Richard Pazdur, Ann T. Farrell, Kirsten B. Goldberg, Gene M. Williams, Rosane Charlab, Christopher M. Sheth, Yuan-Li Shen, Albert Deisseroth, Donna Przepiorka, Sarah E. Dorff, Ramadevi Gudi, Vicky Hsu, Lola Luo, Kelly J. Norsworthy
The FDA approved ivosidenib (Tibsovo; Agios), a small-molecule inhibitor of isocitrate dehydrogenase (IDH)1 on July 20, 2018, for treatment of adults with relapsed or refractory acute myeloid leukemia (R/R AML) with susceptible IDH1 mutation as detec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::73f76bad34dda06affe9b958f7b8772b
https://doi.org/10.1158/1078-0432.c.6527243
https://doi.org/10.1158/1078-0432.c.6527243
Autor:
Richard Pazdur, Ann T. Farrell, Reena Philip, Albert Deisseroth, Rajeshwari Sridhara, Donna Roscoe, Yuan Li Shen, Donna Przepiorka, Aaron Schetter, Qing Xu, Emily Y. Jen
Grade >/= 3 AR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c6276fd3c35307dfac0d1990907313a
https://doi.org/10.1158/1078-0432.22474191
https://doi.org/10.1158/1078-0432.22474191
Autor:
Richard Pazdur, Ann T. Farrell, Reena Philip, Albert Deisseroth, Rajeshwari Sridhara, Donna Roscoe, Yuan Li Shen, Donna Przepiorka, Aaron Schetter, Qing Xu, Emily Y. Jen
Literature review - efficacy by log-group MRD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4533a738fd2cd2640d0732376bb01c67
https://doi.org/10.1158/1078-0432.22474188.v1
https://doi.org/10.1158/1078-0432.22474188.v1
Autor:
Richard Pazdur, R. Angelo de Claro, Ann T. Farrell, Julia A. Beaver, Rajeshwari Sridhara, Dickran Kazandjian, Albert Deisseroth, Sarah E. Dorff, Rosane Charlab, Donna Przepiorka, Ashley F. Ward, Emma C. Scott, Flora Mulkey, Kelly J. Norsworthy
Supplementary Figure 1. Detailed flow diagram for ascertainment of DS cases.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92fb0954902c2407558ec6d5284e8399
https://doi.org/10.1158/1078-0432.22476204.v1
https://doi.org/10.1158/1078-0432.22476204.v1